New findings link EZH2 to TNBC metastasis and chromosomal instability Triple negative breast cancer (TNBC) remains one of the most challenging cancer types to treat, largely due to its propensity to spread to distant organs. A new preclinical study led by Weill Cornell Medicine uncovers a surprising mechanism: an enzyme called EZH2 drives abnormal cell…